{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:15:49Z","timestamp":1781075749390,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05320-7","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:57:57Z","timestamp":1680501477000},"page":"1445-1451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic\/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4534-4929","authenticated-orcid":false,"given":"Zehra","family":"Ozsoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ekici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"K\u0131l\u0131c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Sar\u0131bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bur\u00e7in","family":"Sener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"issue":"2","key":"5320_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/rheumatology\/kem351","volume":"47","author":"R Dinser","year":"2008","unstructured":"Dinser R, Fousse M, Sester U, Albrecht K, Singh M, Kohler H, Muller-Ladner U, Sester M (2008) Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) 47(2):212\u2013218. https:\/\/doi.org\/10.1093\/rheumatology\/kem351","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"5320_CR2","doi-asserted-by":"publisher","first-page":"e0119260","DOI":"10.1371\/journal.pone.0119260","volume":"10","author":"H Lee","year":"2015","unstructured":"Lee H, Park HY, Jeon K, Jeong BH, Hwang JW, Lee J, Cha HS, Koh EM, Kang ES, Koh WJ (2015) QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment. PLoS ONE 10(3):e0119260. https:\/\/doi.org\/10.1371\/journal.pone.0119260","journal-title":"PLoS ONE"},{"issue":"5","key":"5320_CR3","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s10067-020-05443-3","volume":"40","author":"E Seyhoglu","year":"2021","unstructured":"Seyhoglu E, Uyaroglu OA, Erden A, Kilic L, Karadag O, Akdogan A, Bilgen SA, Ertenli I, Kiraz S, Kalyoncu U (2021) QuantiFERON(R)-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guerin (BCG)-vaccinated country: the HUR-BIO single-center real-life results. Clin Rheumatol 40(5):2027\u20132035. https:\/\/doi.org\/10.1007\/s10067-020-05443-3","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5320_CR4","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM, Carreno L, Figueroa M, Group B (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52(6):1766\u20131772. https:\/\/doi.org\/10.1002\/art.21043","journal-title":"Arthritis Rheum"},{"key":"5320_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223335","author":"GE Fragoulis","year":"2022","unstructured":"Fragoulis GE, Nikiphorou E, Dey M et al (2022) EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases [published online ahead of print, 2022 Nov 3]. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223335","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5320_CR6","first-page":"1192","volume":"10","author":"M Farhat","year":"2006","unstructured":"Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10(11):1192\u20131204","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"5320_CR7","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1109\/JSEN.2014.2305152","volume":"14","author":"HC Koydemir","year":"2014","unstructured":"Koydemir HC, Kulah H, Alp A, Uner AH, Hascelik G, Ozgen C (2014) A Fully microfabricated electrochemical sensor and its implementation for detection of methicillin resistance in Staphylococcus aureus. IEEE Sens J 14(6):1844\u20131851. https:\/\/doi.org\/10.1109\/JSEN.2014.2305152","journal-title":"IEEE Sens J"},{"issue":"5","key":"5320_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM (2016) First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J 48(5):1411\u20131419. https:\/\/doi.org\/10.1183\/13993003.00510-2016","journal-title":"Eur Respir J"},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tube.2018.10.014","volume":"113","author":"NP Allen","year":"2018","unstructured":"Allen NP, Swarbrick G, Cansler M, Null M, Salim H, Miyamasu M, Howard J, Boyle J, Lewinsohn D, Lewinsohn D (2018) Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes. Tuberculosis (Edinb) 113:239\u2013241. https:\/\/doi.org\/10.1016\/j.tube.2018.10.014","journal-title":"Tuberculosis (Edinb)"},{"issue":"8","key":"5320_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrrheum.2017.81","volume":"13","author":"E Nikiphorou","year":"2017","unstructured":"Nikiphorou E, Buch MH, Hyrich KL (2017) Biologics registers in RA: methodological aspects, current role and future applications. Nat Rev Rheumatol 13(8):503\u2013510. https:\/\/doi.org\/10.1038\/nrrheum.2017.81","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"5320_CR11","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.21037\/jtd.2019.12.11","volume":"11","author":"JY Hong","year":"2019","unstructured":"Hong JY, Park SY, Kim A, Cho SN, Hur YG (2019) Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. J Thorac Dis 11(12):5210\u20135217. https:\/\/doi.org\/10.21037\/jtd.2019.12.11","journal-title":"J Thorac Dis"},{"key":"5320_CR12","unstructured":"QIAGEN (2016) QuantiFERON-TB Gold plus (QFT-Plus) ELISA Package Insert Rev. 04."},{"issue":"1","key":"5320_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1465-9921-7-56","volume":"7","author":"I Brock","year":"2006","unstructured":"Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P (2006) Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 7(1):56. https:\/\/doi.org\/10.1186\/1465-9921-7-56","journal-title":"Respir Res"},{"issue":"7","key":"5320_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","volume":"175","author":"AF Luetkemeyer","year":"2007","unstructured":"Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV (2007) Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 175(7):737\u2013742. https:\/\/doi.org\/10.1164\/rccm.200608-1088OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5320_CR15","first-page":"776","volume":"35","author":"D Ponce de Leon","year":"2008","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M (2008) Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 35(5):776\u2013781","journal-title":"J Rheumatol"},{"issue":"2","key":"5320_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jiac.2017.09.012","volume":"24","author":"H Igari","year":"2018","unstructured":"Igari H, Ishikawa S, Nakazawa T, Oya Y, Futami H, Tsuyuzaki M, Suzuki K, Matsumura R (2018) Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. J Infect Chemother 24(2):110\u2013116. https:\/\/doi.org\/10.1016\/j.jiac.2017.09.012","journal-title":"J Infect Chemother"},{"issue":"1","key":"5320_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/ard.2008.101857","volume":"69","author":"J Martin","year":"2010","unstructured":"Martin J, Walsh C, Gibbs A, McDonnell T, Fearon U, Keane J, Codd MB, Dodd J, Veale D, Fitzgerald O, Bresnihan B (2010) Comparison of interferon gamma release assays and conventional screening tests before tumour necrosis factor alpha blockade in patients with inflammatory arthritis. Ann Rheum Dis 69(1):181\u2013185. https:\/\/doi.org\/10.1136\/ard.2008.101857","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5320_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/ard.2007.070789","volume":"67","author":"G Matulis","year":"2008","unstructured":"Matulis G, Juni P, Villiger PM, Gadola SD (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 67(1):84\u201390. https:\/\/doi.org\/10.1136\/ard.2007.070789","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5320_CR19","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/ibd.21605","volume":"17","author":"E Belard","year":"2011","unstructured":"Belard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK, Thomsen H, Brylov A, Hetland ML, Nordgaard-Lassen I, Ravn P (2011) Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis 17(11):2340\u20132349. https:\/\/doi.org\/10.1002\/ibd.21605","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"5320_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1172\/JCI107591","volume":"53","author":"DT Yu","year":"1974","unstructured":"Yu DT, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV (1974) Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest 53(2):565\u2013571. https:\/\/doi.org\/10.1172\/JCI107591","journal-title":"J Clin Invest"},{"issue":"4","key":"5320_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/ard.2009.113829","volume":"69","author":"S Kleinert","year":"2010","unstructured":"Kleinert S, Kurzai O, Elias J, Marten K, Engelke C, Feuchtenberger M, Sandstede J, Frosch M, Tony HP, Kneitz C (2010) Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis 69(4):782\u2013784. https:\/\/doi.org\/10.1136\/ard.2009.113829","journal-title":"Ann Rheum Dis"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","volume":"108","author":"ED Pieterman","year":"2018","unstructured":"Pieterman ED, Liqui Lung FG, Verbon A, Bax HI, Ang CW, Berkhout J, Blaauw G, Brandenburg A, van Burgel ND, Claessen A, van Dijk K, Heron M, Hooghiemstra M, Leussenkamp-Hummelink R, van Lochem E, van Loo IHM, Mulder B, Ott A, Pontesilli O, Reuwer A, Rombouts P, Saegeman V, Scholing M, Vainio S, de Steenwinkel JEM (2018) A multicentre verification study of the QuantiFERON((R))-TB Gold Plus assay. Tuberculosis (Edinb) 108:136\u2013142. https:\/\/doi.org\/10.1016\/j.tube.2017.11.014","journal-title":"Tuberculosis (Edinb)"},{"key":"5320_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00985-19","author":"TK Venkatappa","year":"2019","unstructured":"Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, Belknap RW, Ho CS (2019) Comparing QuantiFERON-TB gold plus with other tests to diagnose Mycobacterium tuberculosis infection. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.00985-19","journal-title":"J Clin Microbiol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05320-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T17:04:03Z","timestamp":1686589443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05320-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05320-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EB received honorary from AbbVie, Novartis, and UCB-Pharma. SK received honorary from AbbVie, Amgen, Johnson, and Johnson, MSD, Novartis, Pfizer, Roche, and UCB-Pharma. OK received honorary from AbbVie, Aristea, Roche, Novartis, Viela-Bio, Zenas Biopharma, Abdi \u0130brahim, Celltrion, UCB-Pharma, and Menarini. All of the other authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical approval was obtained from Hacettepe University Institutional Review Board (GO21\/595, 04\/05\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from each patient regarding the use of clinical data for research purposes. The study was in accordance with the 2013 amendment of the Helsinki declaration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}